GenSpera Announces Management Changes Mar 22, 2016 05:36PM
GenSpera Engages FLG Partners LLC and Partner Chris Lowe for Strategic Business Advisory Services Mar 11, 2016 07:00AM
GenSpera Issues Letter to Stockholders Jan 6, 2016 07:00AM
GenSpera Announces Private Placement of $2.5 Million Dec 23, 2015 02:45PM
GenSpera to Present at ICV Manhattan Investor Conference Dec 8, 2015 07:00AM


Nov 20, 2015 07:00AM Mipsagargin Demonstrates Clinical Benefit in Subset of Glioblastoma Patients
Nov 13, 2015 07:00AM GenSpera Provides Update on Clinical Development Programs
Oct 29, 2015 08:00AM World-Renowned Neuro-Oncologist Santosh Kesari, MD, PhD Joins GenSpera’s Scientific Advisory Board
Oct 14, 2015 07:00AM GenSpera to Present at the BIO Investor Forum
Sep 9, 2015 08:00AM GenSpera Announces Encouraging Interim Phase II Data for Glioblastoma, Showcases Positive Future for Mipsagargin Across Multiple Types of Solid Tumors
Aug 24, 2015 08:30AM GenSpera to Present at Rodman & Renshaw 17th Annual Global Investment Conference
Aug 10, 2015 08:30AM GenSpera Provides 2nd Quarter Corporate Update
Jul 28, 2015 08:30AM GenSpera Phase II Abstract Accepted for Presentation at the Society of Neuro-Oncology 20th Annual Scientific Meeting
Jul 20, 2015 08:00AM U.S. Court of Appeals Enters Judgment in Favor of GenSpera
Jul 13, 2015 08:30AM Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)
Jul 6, 2015 09:00AM GenSpera Announces Private Placement of $2.5 Million
Jun 17, 2015 08:30AM U.S. Food and Drug Administration's Office of Orphan Products Development Issues Grant Supporting GenSperas Glioblastoma Study
Jun 15, 2015 08:30AM Craig A. Dionne to Speak at BIO International 2015
Jun 9, 2015 08:30AM KTLA TV's Health Smart Showcases GenSpera's Cancer Research
Jun 3, 2015 09:00AM GenSpera's CEO Craig A. Dionne Interviewed on Sirius Radio
May 20, 2015 08:06AM GenSpera's CEO Craig A. Dionne to Present H.C. Wainwright & Co.'s Panel Discussion during ASCO 2015
May 13, 2015 08:09AM GenSpera Expands Phase II Glioblastoma Trial of Mipsagargin
May 11, 2015 09:03AM GenSpera Provides Corporate Update
May 6, 2015 09:13AM GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations
Apr 28, 2015 08:10AM GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen
Mar 30, 2015 08:10AM GenSpera Launches National Investor Relations Program
Mar 17, 2015 08:00AM GenSpera Presents at BIO Asia International Conference